All
Results: 37189-37200 of 85802

CURRENT COMPANY SURVEY / DECISION-MAKERS FROM THE UNITED KINGDOM WANT TO EXPAND ABROAD - GERMANY AND RHEINISCHES REVIER IN DEMAND

Azafaros Announces Initiation of two Global Phase 3 studies with Nizubaglustat in Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses, respectively

AGC’s Group Company in Southeast Asia Obtains International Sustainability and Carbon Certification, “ISCC PLUS Certification”






